• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017 - Product Image

Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017

  • Published: January 2013
  • Region: Global
  • 136 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Ab Sciex
  • Astrazeneca Plc
  • Chenomx
  • Metabolomx
  • Nextgen Metabolomics
  • Sidmap, Llc
  • MORE

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.

Metabolomics Market – Analysis of Global Technology, Application Trends and Landscape 2012-2017 report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as, (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept READ MORE >

1. Introduction
1.1 Key Take-Aways
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data Points From Secondary Sources

2. Executive Summary

3. Metabolomics –Technology Landscape Analysis
3.1 Introduction
3.2 Metabolomics And Metabonomics
3.3 Separation Techniques - High Performance Liquid Chromatography (Hplc)
3.4 Separation Techniques – Capillary Electrophoresis (Ce)
3.5 Detection Techniques – Mass Spectrometry (Ms)
3.6 Detection Techniques – Nuclear Magnetic Resonance (Nmr)
3.7 Detection Techniques – Surface Based Mass Analysis
3.8 Key Application Areas
3.8.1 Biomarker Discovery
3.8.2 Drug Discovery
3.8.3 Toxicity Assessment/Toxicology
3.8.4 Nutri-Genomics
3.9 Conceptual Approach
3.9.1 Target Analysis
3.9.2 Metabolite Profiling
3.9.3 Metabolite Fingerprinting
3.10 Technology Trends In Metabolomics
3.11 Value Chain Analysis

4. Metabolomics – Market Landscape Analysis
4.1 Global Metabolomics Market Segmentation
4.2 Market Forecast
4.2.1 Global Metabolomics Market Revenue Forecast – Introduction
4.2.2 Global Metabolomics Market Revenue – Regional
4.2.3 Global Metabolomics Market Revenue – Indication
4.2.4 Global Metabolomics Market Revenue, By Application
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Challenges
4.3.4 Emerging Trends
4.4 Demand Side Analysis

5. Metabolomics - Technology Investment Potential
5.1 Investment Climate Assessment
5.1.1 Investment Client Networks
5.1.1.1 Funding Bodies
5.1.1.2 Insights On Current & Future Tech-Investment Trend
5.1.2 Funding Opportunities
5.1.3 Analysis Of Potential Areas For Technology Investment Using Strategic Evaluation

6. Metabolomics – Geographical Analysis
6.1 Introduction
6.2 U.S., Canada, Mexico
6.3 Europe
6.4 Asia & Rest Of The World (Row)

7. Competitive Landscape Analysis
7.1 Mergers & Acquisitions
7.2 New Product Developments
7.3 Collaborations

8. Patent Analysis
8.1 Patent Analysis

9. Technology Analysis (Using Multi Criteria Decision Making) & Road Mapping
9.1 Level 0 Criteria Description
9.2 Comparison Of Devices Based On Level 0 Criteria
9.3 Technology Prioritization And Ahp Analysis Findings
9.4 Technology Roadmap

10 Analyst Insights & Recommendations
10.1 Analyst Insights
10.2 Strategic Recommendations For Technology & Business Management

11 Company Profiles
11.1 Agilent Technologies
11.2 Bruker Corporation
11.3 Metabolomic Technologies
11.4 Metabolon
11.5 Chenomx
11.6 Bio-Rad Laboratories
11.7 Waters Corporation
11.8 Human Metabolome Technologies
11.9 Nextgen Metabolomics
11.10 Biocrates Life Sciences Ag
11.11 Stemina Biomarker
11.12 Phenomenome
11.13 Metanomics Gmbh
11.14 Accelrys
11.15 Eisai Co. Ltd.
11.16 Shimadzu Corporation
11.17 Sidmap, Llc
11.18 Astrazeneca Plc
11.19 Ab Sciex
11.20 Metabolomx
11.21 Research Institute Of Chromatography (Ric)

12 Appendix
12.1 Key Patents

13 Glossary

List Of Tables

1 Global Metabolomics Market Revenue, By Regional ($Million)
2 Global Metabolomics Market Revenue, By Indication ($Million)
3 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Oncology Indication
4 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Cardiology Indication
5 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Neurology Indication
6 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Indications
7 Global Metabolomics Market Revenue, By Application ($Million)
8 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Bio Marker Discovery Application
9 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Drug Discovery Application
10 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Toxicology Testing Application
11 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Applications

List Of Other Tables

1 Market Dynamics-Drivers Impact By Timeline
2 Market Dynamics-Restraints Impact By Timeline
3 Opportunity Strategic Evaluation Analysis
4 Mergers And Acquisitions
5 New Product Developments
6 Collaborations
7 Key Patents

List Of Figures

Fig 1 Research Methodology
Fig 2 Global Metabolomics Market Revenue, 2012 – 2017 ($Million)
Fig 3 Market Share By Region, 2012 – 2017 (%)
Fig 4 Key Application Areas
Fig 5 Flow Chart Of Nutri-Genomics
Fig 6 Conceptual Approach
Fig 7 Value Chain Analysis
Fig 8 Percentage Of Stake Holders In Metabolomics Value Chain
Fig 9 Global Metabolomics Market Segmentation
Fig 10 Global Metabolomics Market Revenue Forecast, 2012 - 2017 ($Million)
Fig 11 Global Metabolomics Market Revenue, By Regional ($Million)
Fig 12 Global Metabolomics Market Y-O-Y Growth Rate, By Region
Fig 13 Market Share, By Region, 2012 – 2017 (%)
Fig 14 Global Metabolomics Market Revenue, By Indication ($Million)
Fig 15 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Oncology Indication
Fig 16 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Cardiology Indication
Fig 17 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Neurology Indication
Fig 18 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Indications
Fig 19 Global Market Share, By Indication, 2012 – 2017 (%)
Fig 20 Global Metabolomics Market Revenue, By Application ($Million)
Fig 21 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Bio Marker Discovery Application
Fig 22 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Drug Discovery Application
Fig 23 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Toxicology Testing Application
Fig 24 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Applications
Fig 25 Global Percentage Distribution Of Metabolomics Market, By Applications, 2012 – 2017 (%)
Fig 26 Demand Side Analysis
Fig 27 Investment Client Networks
Fig 28 Opportunity Strategic Evaluation Analysis
Fig 29 Regions With High Technology Adoption
Fig 30 Patent Distribution Among Top Players
Fig 31 Ahp Analysis
Fig 32 Priority Values
Fig 33 Comparison Of Devices Based On Level 0 Criteria
Fig 34 Technology Prioritization And Ahp Analysis Findings
Fig 35 Technology Roadmap
Fig 36 Strategic Recommendations For Technology & Business Management

- Agilent Technologies
- Bruker Corporation
- Metabolomic Technologies
- Metabolon
- Chenomx
- Bio-Rad Laboratories
- Waters Corporation
- Human Metabolome Technologies
- Nextgen Metabolomics
- Biocrates Life Sciences Ag
- Stemina Biomarker
- Phenomenome
- Metanomics Gmbh
- Accelrys
- Eisai Co. Ltd.
- Shimadzu Corporation
- Sidmap, Llc
- Astrazeneca Plc
- Ab Sciex
- Metabolomx
- Research Institute Of Chromatography (Ric)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos